Oxytocin: Parallel Processing in the Social Brain?

Journal of Neuroendocrinology

Volumn 27, Issue 6, 2015, Pages 516-535

  Dölen, Gül ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT; Autism; Oxytocin; Schizophrenia; Synaptic plasticity; Vasopressin

Indexed keywords

OXYTOCIN; OXYTOCIN RECEPTOR;

AUTISM; BRAIN; CLINICAL FEATURE; EMPATHY; HUMAN; NONHUMAN; OXYTOCINERGIC SIGNALLING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; SOCIAL STATUS; ADOLESCENT; ADULT; CHILD; MALE; MEMORY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; CHILD; HUMANS; MALE; MEMORY; OXYTOCIN; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 84929760866     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12284     Document Type: Review

References (344)

1. Farfel M, Azevedo FACC, Carvalho LRBB, Grinberg LEAT, Ferretti RELL, Leite REPP, Filho WJ, Lent R, Farfel JM, Herculano-Houzel S. Equal numbers of neuronal and non-neuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 2009; 513: 532-541.
2. Gasser HS, Erlanger J. The role of fiber size in the establishment of a nerve block by pressure or cocaine. Am J Physiol 1929; 88: 581-591.
3. Bishop GHG. Fiber groups in the optic nerve. Am J Physiol 1933; 106: 460-470.
4. Nassi JJ, Callaway EM. Parallel processing strategies of the primate visual system. Nat Rev Neurosci 2009; 10: 360-372.
5. Dijkerman HC, de Haan EHF. Somatosensory processes subserving perception and action. Behav Brain Sci 2007; 30: 189-201.
6. Recanzone GH, Cohen YE. Serial and parallel processing in the primate auditory cortex revisited. Behav Brain Res 2010; 206: 1-7.
7. Zwergal A, Strupp M, Brandt T, Büttner-Ennever JA. Parallel ascending vestibular pathways: anatomical localization and functional specialization. Ann NY Acad Sci 2009; 1164: 51-59.
8. Roper SD. Parallel processing in mammalian taste buds? Physiol Behav 2009; 97: 604-608.
9. Haberly LB. Parallel-distributed processing in olfactory cortex: new insights from morphological and physiological analysis of neuronal circuitry. Chem Senses 2001; 26: 551-576.
10. Kravitz AV, Freeze BS, Parker PRL, Kay K, Thwin MT, Deisseroth K, Kreitzer AC. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010; 466: 622-626.
11. Lobo MK, Nestler EJ. The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Front Neuroanat 2011; 5: 41.
12. Gittis AH, Kreitzer AC. Striatal microcircuitry and movement disorders. Trends Neurosci 2012; 35: 557-564.
13. Kravitz AV, Tye LD, Kreitzer AC. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 2012; 15: 816-818.
14. Dale HH. On some physiological actions of ergot. J Physiol 1906; 34: 163-206.
15. MacLeod N. On the oxytocic action of quinine, and a method of preventing it; with cases. Br Med J 1883; 1: 352-353.
16. Cory EA. Excitement of premature parturition. Lancet 1840; 35: 149-152.
17. Ott I, Scott JC. The action of infundibulin upon the mammary secretion. Proc Soc Exp Biol Med 1911; 8: 48-49.
18. Kamm O, Aldrich TB, Grote IW, Rowe LW, Bugbee EP. The active principles of the pituitary gland. J Am Chem Soc 1928; 50: 573-598.
19. du Vigneaud V, Ressler C, Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J Biol Chem 1953; 205: 949-957.
20. du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG. The synthesis of oxytocin. J Am Chem Soc 1954; 76: 3115-3121.
21. Stafflinger E, Hansen KK, Hauser F, Schneider M, Cazzamali G, Williamson M, Grimmelikhuijzen CJP. Cloning and identification of an oxytocin/vasopressin-like receptor and its ligand from insects. Proc Natl Acad Sci USA 2008; 105: 3262-3267.
22. Acher R. Molecular evolution of biologically active polypeptides. Proc R Soc Lond B Biol Sci 1980; 210: 21-43.
23. Ruppert S, Scherer G, Schütz G. Recent gene conversion involving bovine vasopressin and oxytocin precursor genes suggested by nucleotide sequence. Nature 1984; 308: 554-557.
24. Seif SM, Robinson AG. Localization and release of neurophysins. Annu Rev Physiol 1978; 40: 345-376.
25. Chauvet MT, Hurpet D, Chauvet J, Acher R. Identification of human neurophysins: complete amino acid sequences of MSEL- and VLDV-neurophysins SerGly-Gln Lys-ProICyscGlyiS. Proc Natl Acad Sci USA 1983; 80: 2839-2843.
26. Whitnall MH, Key S, Ben-Barak Y, Ozato K, Gainer H. Neurophysin in the hypothalamo-neurohypophysial system. II. Immunocytochemical studies of the ontogeny of oxytocinergic and vasopressinergic neurons. J Neurosci 1985; 5: 98-109.
27. Ben-Barak Y, Russell JT, Whitnall MH, Ozato K, Gainer H, Key S. Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J Neurosci 1985; 5: 81-97.
28. Gautvik KM, Lecea LDE, Gautvik VT, Danielson PE, Tranque P, Dopazo ANA, Bloom FE, Sutcliffe JG. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 1996; 93: 8733-8738.
29. Bargmann W, Scharrer E. The site of origin of the hormones of the posterior pituitary. Am Sci 1951; 39: 255-259.
30. Castel M, Morris JF, Road SP. The neurophysin-containing innervation of the forebrain of the mouse. Neuroscience 1988; 24: 937-966.
31. Sawchenko PE, Swanson LW. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 1982; 205: 260-272.
32. Caff AR, Van Leeuwen FW. Cell and tissue vasopressin-immunoreactive cells in the dorsomedial hypothalamic region, medial amygdaloid nucleus and locus coeruleus of the rat. Cell Tissue Res 1983; 233: 23-33.
33. Van Leeuwen F, Caff R. Cell and tissue vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat. Cell Tissue Res 1983; 228: 525-534.
34. Tobin VA, Hashimoto H, Wacker DW, Takayanagi Y, Langnaese K, Caquineau C, Noack J, Landgraf R, Onaka T, Leng G, Meddle SL, Engelmann M, Ludwig M. An intrinsic vasopressin system in the olfactory bulb is involved in social recognition. Nature 2010; 464: 413-417.
35. Buijs RM. Cell and tissue intra- and extrahypothalamic vasopressin and oxytocin pathways in the Rat. Cell Tissue Res 1978; 192: 423-435.
36. Fliers E, Guldenaar SEF, Wal NVD, Swaab DF. Extrahypothalamic vasopressin and oxytocin in the human brain; presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Res 1986; 375: 363-367.
37. Ni R-J, Shu Y-M, Wang J, Yin J-C, Xu L, Zhou J-N. Distribution of vasopressin, oxytocin and vasoactive intestinal polypeptide in the hypothalamus and extrahypothalamic regions of tree shrews. Neuroscience 2014; 265: 124-136.
38. van Eerdenburg FJ, Swaab DF, van Leeuwen FW. Distribution of vasopressin and oxytocin cells and fibres in the hypothalamus of the domestic pig (Sus scrofa). J Comp Neurol 1992; 318: 138-146.
39. Rosen GJ, de Vries GJ, Goldman SL, Goldman BD, Forger NG. Distribution of oxytocin in the brain of a eusocial rodent. Neuroscience 2008; 155: 809-817.
40. Wang Z, Moody K, Newman JD, Insel TR. Vasopressin and oxytocin immunoreactive neurons and fibers in the forebrain of male and female common marmosets (Callithrix jacchus). Synapse 1997; 27: 14-25.
41. Broad KD, Kendrick KM, Sirinathsinghji DJS, Keverne EB, Broad D. Changes in oxytocin immunoreactivity and mRNA expression in the sheep brain during pregnancy, oestrogen and progesterone. J Neuroendocrinol 1993; 5: 435-444.
42. Richard S, Zingg HH. The human oxytocin gene promoter is regulated by estrogens. J Biol Chem 1990; 265: 6098-6103.
43. Burbach JPH, Adan RAH, van Tol HHM, Verbeeck MAE, Axelson JF, van Leeuwen FW, Beekman JM, Ab G. Regulation of the rat oxytocin gene by estradiol. J Neuroendocrinol 1990; 2: 633-639.
44. Stedronsky K, Telgmann R, Tillmann G, Walther N, Ivell R. The affinity and activity of the multiple hormone response element in the proximal promoter of the human oxytocin gene. J Neuroendocrinol 2002; 14: 472-485.
45. Adan RA, Cox JJ, Beischlag TV, Burbach JP. A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol Endocrinol 1993; 7: 47-57.
46. Hiroi R, Lacagnina AF, Hinds LR, Carbone DG, Uht RM, Handa RJ. The androgen metabolite, 5α-androstane-3β, 17β-diol (3β-diol), activates the oxytocin promoter through an estrogen receptor-β pathway. Endocrinology 2013; 154: 1802-1812.
47. Choi J-W, Kang S-M, Lee Y, Hong S-H, Sanek NA, Young WS, Lee H-J. MicroRNA profiling in the mouse hypothalamus reveals oxytocin-regulating microRNA. J Neurochem 2013; 126: 331-337.
48. Freund-Mercier MJ, Stoeckel ME, Klein MJ. Oxytocin receptors on oxytocin neurones: histoautoradiographic detection in the lactating rat. J Physiol 1994; 480: 155-161.
49. Dölen G, Darvishzadeh A, Huang KW, Malenka RC. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 2013; 501: 179-184.
50. Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T, Nishimori K. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 2009; 29: 2259-2271.
51. 2+ concentration of isolated rat supraoptic cells in response to oxytocin. J Physiol 1994; 478: 275-287.
52. Jørgensen H, Riis M, Knigge U, Kjaer A, Warberg J. Serotonin receptors involved in vasopressin and oxytocin secretion. J Neuroendocrinol 2003; 15: 242-249.
53. Siljee JE, Unmehopa UA, Kalsbeek A, Swaab DF, Fliers E, Alkemade A. Melanocortin 4 receptor distribution in the human hypothalamus. Eur J Endocrinol 2013; 168: 361-369.
54. Luce V, Fernandez Solari J, Rettori V, De Laurentiis A. The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide. Regul Pept 2014; 188: 31-39.
55. Chocyk A, Szumierz K, Wedzony K, Czyrak A. Distribution of dopamine D1 receptors in the paraventricular nucleus of the rat hypothalamus and their colocalization with phosphorylated forms of CREB protein. Folia Med Cracov 2000; 41: 69-86.
56. Young WS, Shepard E, Amico J, Hennighausen L, Wagner KU, LaMarca ME, McKinney C, Ginns EI. Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J Neuroendocrinol 1996; 8: 847-853.
57. Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci USA 1996; 93: 11699-11704.
58. Gross GA, Imamura T, Luedke C, Vogt SK, Olson LM, Nelson DM, Sadovsky Y, Muglia LJ. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc Natl Acad Sci USA 1998; 95: 11875-11879.
59. Jin D, Liu H-X, Hirai H, Torashima T, Nagai T, Lopatina O, Shnayder NA, Yamada K, Noda M, Seike T, Fujita K, Takasawa S, Yokoyama S, Koizumi K, Shiraishi Y, Tanaka S, Hashii M, Yoshihara T, Higashida K, Islam MS, Yamada N, Hayashi K, Noguchi N, Kato I, Okamoto H, Matsushima A, Salmina A, Munesue T, Shimizu N, Mochida S, Asano M, Higashida H. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 2007; 446: 41-45.
60. Fields RL, Ponzio TA, Kawasaki M, Gainer H. Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo. PLoS One 2012; 7: e32085.
61. Knobloch HS, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH, Osten P, Schwarz MK, Seeburg PH, Stoop R, Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012; 73: 553-566.
62. Wu Z, Xu Y, Zhu Y, Sutton AK, Zhao R, Lowell BB, Olson DP, Tong Q. An obligate role of oxytocin neurons in diet induced energy expenditure. PLoS One 2012; 7: e45167.
63. Kubota Y, Kimura T, Hashimoto K, Tokugawa Y, Nobunaga K, Azuma C, Saji F, Murata Y. Structure and expression of the mouse oxytocin receptor gene. Mol Cell Endocrinol 1996; 124: 25-32.
64. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H. Structure and expression of a human oxytocin receptor. Nature 1992; 356: 526-529.
65. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81: 629-683.
66. Hoyle CHV. Neuropeptide families and their receptors: evolutionary perspectives. Brain Res 1999; 848: 1-25.
67. Busnelli M, Bulgheroni E, Manning M, Kleinau G, Chini B. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors. J Pharmacol Exp Ther 2013; 346: 318-327.
68. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 2006; 7: 126-136.
69. Ross HE, Cole CD, Smith Y, Neumann ID, Landgraf R, Murphy AZ, Young LJ. Characterization of the oxytocin system regulating affiliative behavior in female prairie voles. Neuroscience 2009; 162: 892-903.
70. Yoshimura R, Kiyama H, Kimura T, Araki T, Maeno H, Tanizawa O, Tohyama M. Localization of oxytocin receptor messenger ribonucleic acid in the rat brain. Endocrinology 1993; 133: 1239-1246.
71. Vaccari C, Lolait SJ, Ostrowski NL. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 1998; 139: 5015-5033.
72. Nishimori K, Takayanagi Y, Yoshida M, Kasahara Y, Young LJ, Kawamata M. New aspects of oxytocin receptor function revealed by knockout mice: sociosexual behaviour and control of energy balance. Prog Brain Res 2008; 170: 79-90.
73. Van den Pol AN. Neuropeptide transmission in brain circuits. Neuron 2012; 76: 98-115.
74. Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci USA 2005; 102: 16096-16101.
75. Lee H-J, Caldwell HK, Macbeth AH, Tolu SG, Young WS. A conditional knockout mouse line of the oxytocin receptor. Endocrinology 2008; 149: 3256-3263.
76. Iida A, Saito S, Sekine A, Kataoka Y, Tabei W, Nakamura Y. Catalog of 300 SNPs in 23 genes encoding G-protein coupled receptors. J Hum Genet 2004; 49: 194-208.
77. Bakermans-Kranenburg MJ, van Ijzendoorn MH. A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans. Psychiatr Genet 2014; 24: 45-51.
78. Gurdjian ES. The diencephalon of the albino rat: studies on the brain of the rat. No. 2. J Comp Neurol 1927; 43: 1-114.
79. Krieg WJS. The hypothalamus of the albino rat. J Comp Neurol 1932; 55: 19-89.
80. van den Pol AN. The magnocellular and parvocellular paraventricular nucleus of rat: intrinsic organization. J Comp Neurol 1982; 206: 317-345.
81. Zhang L, Hernández VS. Synaptic innervation to rat hippocampus by vasopressin-immuno-positive fibres from the hypothalamic supraoptic and paraventricular nuclei. Neuroscience 2013; 228: 139-162.
82. Castel M, Morris J, Belenky M. Non-synaptic and dendritic exocytosis from dense-cored vesicles in the suprachiasmatic nucleus. NeuroReport 1996; 7: 543-547.
83. Swanson LW, Kuypers HG. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 1980; 194: 555-570.
84. Hosoya Y, Matsushita M. Identification and distribution of the spinal and hypophyseal projection neurons in the paraventricular nucleus of the rat. A light and electron microscopic study with the horseradish peroxidase method. Exp Brain Res 1979; 35: 315-331.
85. Biag J, Huang Y, Gou L, Hintiryan H, Askarinam A, Hahn JD, Toga AW, Dong H-W. Cyto- and chemoarchitecture of the hypothalamic paraventricular nucleus in the C57BL/6J male mouse: a study of immunostaining and multiple fluorescent tract tracing. J Comp Neurol 2012; 520: 6-33.
86. Klyachko VA, Jackson MB. Capacitance steps and fusion pores of small and large-dense-core vesicles in nerve terminals. Nature 2002; 418: 89-92.
87. de Kock CPJ, Wierda KDB, Bosman LWJ, Min R, Koksma J-J, Mansvelder HD, Verhage M, Brussaard AB. Somatodendritic secretion in oxytocin neurons is upregulated during the female reproductive cycle. J Neurosci 2003; 23: 2726-2734.
88. Pow DV, Morris JF. Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience 1989; 32: 435-439.
89. Landry M, Vila-Porcile E, Hökfelt T, Calas A. Differential routing of coexisting neuropeptides in vasopressin neurons. Eur J Neuorsci 2003; 17: 579-589.
90. Simmons ML, Terman GW, Gibbs SM, Chavkin C. L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron 1995; 14: 1265-1272.
91. Mens WB, Witter A, van Wimersma Greidanus TB. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res 1983; 262: 143-149.
92. Lee H-J, Macbeth AH, Pagani JH, Young WS. Oxytocin: the great facilitator of life. Prog Neurobiol 2009; 88: 127-151.
93. Dulac C, Wu Z, O'Connell LA. Neural control of maternal and paternal behaviors. Science 2014; 345: 765-770.
94. Rilling JK, Young LJ. The biology of mammalian parenting and its effect on offspring social development. Science 2014; 345: 771-776.
95. Shultz S, Opie C, Atkinson QD. Stepwise evolution of stable sociality in primates. Nature 2011; 479: 219-222.
96. Dale HH. The action of extracts of the pituitary body. Biochem J 1909; 4: 427-447.
97. Hawkins JS, Wing DA. Current pharmacotherapy options for labor induction. Expert Opin Pharmacother 2012; 13: 2005-2014.
98. Francis DD, Champagne FC, Meaney MJ. Variations in maternal behaviour are associated with differences in oxytocin receptor levels in the rat. J Neuroendocrinol 2000; 12: 1145-1148.
99. Francis DD, Young LJ, Meaney MJ, Insel TR. Naturally occurring differences in maternal care are associated with the expression of oxytocin and vasopressin (V1a) receptors: gender differences. J Neuroendocrinol 2002; 14: 349-353.
100. Meddle SL, Bishop VR, Gkoumassi E, van Leeuwen FW, Douglas AJ. Dynamic changes in oxytocin receptor expression and activation at parturition in the rat brain. Endocrinology 2007; 148: 5095-5104.
101. Wang ZX, Liu Y, Young LJ, Insel TR. Hypothalamic vasopressin gene expression increases in both males and females postpartum in a biparental rodent. J Neuroendocrinol 2000; 12: 111-120.
102. Champagne F, Diorio J, Sharma S, Meaney MJ. Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc Natl Acad Sci USA 2001; 98: 12736-12741.
103. Olazábal DE, Young LJ. Species and individual differences in juvenile female alloparental care are associated with oxytocin receptor density in the striatum and the lateral septum. Horm Behav 2006; 49: 681-687.
104. Summerlee AJ, Lincoln DW. Electrophysiological recordings from oxytocinergic neurones during suckling in the unanaesthetized lactating rat. J Endocrinol 1981; 90: 255-265.
105. Wakerley JB, Lincoln DW. The milk-ejection reflex of the rat: a 20- to 40-fold acceleration in the firing of paraventricular neurones during oxytocin release. J Endocrinol 1973; 57: 477-493.
106. Moos FC. GABA-induced facilitation of the periodic bursting activity of oxytocin neurones in suckled rats. J Physiol 1995; 488: 103-114.
107. Lincoln DW, Wakerley JB. Electrophysiological evidence for the activation of supraoptic neurones during the release of oxytocin. J Physiol 1974; 242: 533-554.
108. Neumann I, Pittman QJ, Landgraf R. Release of oxytocin within the supraoptic nucleus. Mechanisms, physiological significance and antisense targeting. Adv Exp Med Biol 1995; 395: 173-183.
109. Neumann I, Russell JA, Landgraf R. Oxytocin and vasopressin release within the supraoptic and paraventricular nuclei of pregnant, parturient and lactating rats: a microdialysis study. Neuroscience 1993; 53: 65-75.
110. Neumann I, Ludwig M, Engelmann M, Pittman QJ, Landgraf R. Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology 1993; 58: 637-645.
111. Olazábal DE, Young LJ. Oxytocin receptors in the nucleus accumbens facilitate 'spontaneous' maternal behavior in adult female prairie voles. Neuroscience 2006; 141: 559-568.
112. Febo M, Numan M, Ferris CF. Functional magnetic resonance imaging shows oxytocin activates brain regions associated with mother-pup bonding during suckling. J Neurosci 2005; 25: 11637-11644.
113. Veening JG, de Jong TR, Waldinger MD, Korte SM, Olivier B. The role of oxytocin in male and female reproductive behavior. Eur J Pharmacol 2015; 753: 209-228.
114. Vignozzi L, Filippi S, Luconi M, Morelli A, Mancina R, Marini M, Vannelli GB, Granchi S, Orlando C, Gelmini S, Ledda F, Forti G, Maggi M. Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology 2004; 145: 1823-1834.
115. Benelli A, Poggioli R, Luppi P, Ruini L, Bertolini A, Arletti R. Oxytocin enhances, and oxytocin antagonism decreases, sexual receptivity in intact female rats. Neuropeptides 1994; 27: 245-250.
116. Blaicher W, Gruber D, Bieglmayer C, Blaicher AM, Knogler W, Huber JC. The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest 1999; 47: 125-126.
117. Charmichael MS, Humber R, Dixen J, Palmisano G, Greenleaf W, Davidson JM. Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab 1986; 64: 27-31.
118. Salonia A, Nappi RE, Pontillo M, Daverio R, Smeraldi A, Briganti A, Fabbri F, Zanni G, Rigatti P, Montorsi F. Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm Behav 2005; 47: 164-169.
119. Insel TR. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010; 65: 768-779.
120. Young LJ, Wang Z. The neurobiology of pair bonding. Nat Neurosci 2004; 7: 1048-1054.
121. Scheele D, Wille A, Kendrick KM, Stoffel-Wagner B, Becker B, Güntürkün O, Maier W, Hurlemann R. Oxytocin enhances brain reward system responses in men viewing the face of their female partner. Proc Natl Acad Sci USA 2013; 110: 20308-20313.
122. Loth E, Poline J-B, Thyreau B, Jia T, Tao C, Lourdusamy A, Stacey D, Cattrell A, Desrivières S, Ruggeri B, Fritsch V, Banaschewski T, Barker GJ, Bokde ALW, Büchel C, Carvalho FM, Conrod PJ, Fauth-Buehler M, Flor H, Gallinat J, Garavan H, Heinz A, Bruehl R, Lawrence C, Mann K, Martinot J-L, Nees F, Paus T, Pausova Z, Poustka L, Rietschel M, Smolka M, Struve M, Feng J, Schumann G. Oxytocin receptor genotype modulates ventral striatal activity to social cues and response to stressful life events. Biol Psychiatry 2014; 76: 367-376.
123. Mottolese R, Redouté J, Costes N, Le Bars D, Sirigu A. Switching brain serotonin with oxytocin. Proc Natl Acad Sci USA 2014; 111: 8637-8642.
124. Makani V, Sultana R, Sie KS, Orjiako D, Tatangelo M, Dowling A, Cai J, Pierce W, Allan Butterfield D, Hill J, Park J. Annexin A1 complex mediates oxytocin vesicle transport. Schizophr Res 2013; 25: 1241-1254.
125. Zhang Z, Bhalla A, Dean C, Chapman ER, Jackson MB. Synaptotagmin IV: a multifunctional regulator of peptidergic nerve terminals. Nat Neurosci 2009; 12: 163-171.
126. Zhang G, Bai H, Zhang H, Dean C, Wu Q, Li J, Guariglia S, Meng Q, Cai D. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron 2011; 69: 523-535.
127. Sieburth D, Ch'ng Q, Dybbs M, Tavazoie M, Kennedy S, Wang D, Dupuy D, Rual J-F, Hill DE, Vidal M, Ruvkun G, Kaplan JM. Systematic analysis of genes required for synapse structure and function. Nature 2005; 436: 510-517.
128. Sieburth D, Madison JM, Kaplan JM. PKC-1 regulates secretion of neuropeptides. Nat Neurosci 2007; 10: 49-57.
129. Hennessy MB, Kaiser S, Sachser N. Social buffering of the stress response: diversity, mechanisms, and functions. Front Neuroendocrinol 2009; 30: 470-482.
130. Windle RJ, Shanks N, Lightman SL, Ingram CD. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997; 138: 2829-2834.
131. Waldherr M, Neumann ID. Centrally released oxytocin mediates mating-induced anxiolysis in male rats. Proc Natl Acad Sci USA 2007; 104: 16681-16684.
132. Smith AS, Wang Z. Hypothalamic oxytocin mediates social buffering of the stress response. Biol Psychiatry 2014; 76: 281-288.
133. Winslow JT, Noble PL, Lyons CK, Sterk SM, Insel TR. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology 2003; 28: 910-918.
134. Huber D, Veinante P, Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005; 308: 245-248.
135. Viviani D, Charlet A, van den Burg E, Robinet C, Hurni N, Abatis M, Magara F, Stoop R. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 2011; 333: 104-107.
136. Guzmán YF, Tronson NC, Sato K, Mesic I, Guedea AL, Nishimori K, Radulovic J. Role of oxytocin receptors in modulation of fear by social memory. Psychopharmacology 2014; 231: 2097-2105.
137. Guzmán YF, Tronson NC, Jovasevic V, Sato K, Guedea AL, Mizukami H, Nishimori K, Radulovic J. Fear-enhancing effects of septal oxytocin receptors. Nat Neurosci 2013; 16: 1185-1187.
138. Knobloch HS, Grinevich V. Evolution of oxytocin pathways in the brain of vertebrates. Front Behav Neurosci 2014; 8: 31.
139. Bale TL, Davis AM, Auger AP, Dorsa DM, McCarthy MM. CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 2001; 21: 2546-2552.
140. Pagani JH, Lee H-J, Young WS. Postweaning, forebrain-specific perturbation of the oxytocin system impairs fear conditioning. Genes Brain Behav 2011; 10: 710-719.
141. Ferguson JN, Aldag JM, Insel TR, Young LJ. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 2001; 21: 8278-8285.
142. Choleris E, Little SR, Mong JA, Puram SV, Langer R, Pfaff DW. Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice. Proc Natl Acad Sci USA 2007; 104: 4670-4675.
143. Pobbe RLH, Pearson BL, Defensor EB, Bolivar VJ, Young WS, Lee H-J, Blanchard DC, Blanchard RJ. Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors. Horm Behav 2012; 61: 436-444.
144. Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, Capurro V, Finardi A, Donzelli A, Pattini L, Rubino T, Parolaro D, Nishimori K, Parenti M, Chini B. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry 2011; 69: 875-882.
145. Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 2010; 11: 490-502.
146. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004; 3: 287-302.
147. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 2004; 3: 303-314.
148. Crawley JN, Chen T, Puri A, Washburn R, Sullivan TL, Hill JM, Young NB, Nadler JJ, Moy SS, Young LJ, Caldwell HK, Young WS. Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments. Neuropeptides 2007; 41: 145-163.
149. Hammock EAD, Levitt P. Oxytocin receptor ligand binding in embryonic tissue and postnatal brain development of the C57BL/6J mouse. Front Behav Neurosci 2013; 7: 195.
150. Stachowiak A, Macchi C, Nussdorfer GG, Malendowicz LK. Effects of oxytocin on the function and morphology of the rat adrenal cortex: in vitro and in vivo investigations. Res Exp Med 1995; 195: 265-274.
151. Chiodera P, Legros JJ. Intravenous injection of synthetic oxytocin induces a decrease of cortisol plasma level in normal man. C R Seances Soc Biol Fil 1981; 175: 546-549.
152. Legros JJ, Chiodera P, Geenen V, Smitz S, von Frenckell R. Dose-response relationship between plasma oxytocin and cortisol and adrenocorticotropin concentrations during oxytocin infusion in normal men. J Clin Endocrinol Metab 1984; 58: 105-109.
153. de Oliveira LF, Camboim C, Diehl F, Consiglio AR, Quillfeldt JA. Glucocorticoid-mediated effects of systemic oxytocin upon memory retrieval. Neurobiol Learn Mem 2007; 87: 67-71.
154. Ayers LW, Missig G, Schulkin J, Rosen JB. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration. Neuropsychopharmacology 2011; 36: 2488-2497.
155. Missig G, Ayers LW, Schulkin J, Rosen JB. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology 2010; 35: 2607-2616.
156. Norman GJ, Hawkley L, Luhmann M, Ball AB, Cole SW, Berntson GG, Cacioppo JT. Variation in the oxytocin receptor gene influences neurocardiac reactivity to social stress and HPA function: a population based study. Horm Behav 2012; 61: 134-139.
157. Kovács GL, Vécsei L, Telegdy G. Opposite action of oxytocin to vasopressin in passive avoidance behavior in rats. Physiol Behav 1978; 20: 801-802.
158. Wu W, Yu L-C. Roles of oxytocin in spatial learning and memory in the nucleus basalis of Meynert in rats. Regul Pept 2004; 120: 119-125.
159. Ferrier BM, Kennett DJ, Devlin MC. Influence of oxytocin on human memory processes. Life Sci 1980; 27: 2311-2317.
160. Kennett DJ, Devlin MC, Ferrier BM. Influence of oxytocin on human memory processes: validation by a control study. Life Sci 1982; 31: 273-275.
161. Landgraf R, Ermisch A, Hess J. Indications for a brain uptake of labelled vasopressin and ocytocin and the problem of the blood-brain barrier. Endokrinologie 1979; 73: 77-81.
162. Kogan JH, Frankland PW, Silva AJ. Long-term memory underlying hippocampus-dependent social recognition in mice. Hippocampus 2000; 10: 47-56.
163. Hitti FL, Siegelbaum SA. The hippocampal CA2 region is essential for social memory. Nature 2014; 508: 88-92.
164. Tomizawa K, Iga N, Lu Y-F, Moriwaki A, Matsushita M, Li S-T, Miyamoto O, Itano T, Matsui H. Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci 2003; 6: 384-390.
165. Owen SF, Tuncdemir SN, Bader PL, Tirko NN, Fishell G, Tsien RW. Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature 2013; 500: 458-462.
166. Cohen H, Kaplan Z, Kozlovsky N, Gidron Y, Matar MA, Zohar J. Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses. J Neuroendocrinol 2010; 22: 889-904.
167. Eckstein M, Becker B, Scheele D, Scholz C, Preckel K, Schlaepfer TE, Grinevich V, Kendrick KM, Maier W, Hurlemann R. Oxytocin facilitates the extinction of conditioned fear in humans. Biol Psychiatry 2014; doi:10.1016/j.biopsych.2014.10.015.
168. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 2005; 25: 11489-11493.
169. Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 2007; 62: 1187-1190.
170. Gamer M, Zurowski B, Büchel C. Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc Natl Acad Sci USA 2010; 107: 9400-9405.
171. Petrovic P, Kalisch R, Singer T, Dolan RJ. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 2008; 28: 6607-6615.
172. Riem MME, Bakermans-Kranenburg MJ, Pieper S, Tops M, Boksem MAS, Vermeiren RRJM, Van Ijzendoorn MH, Rombouts SARB. Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized controlled trial. Biol Psychiatry 2011; 70: 291-297.
173. Herzmann G, Bird CW, Freeman M, Curran T. Effects of oxytocin on behavioral and ERP measures of recognition memory for own-race and other-race faces in women and men. Psychoneuroendocrinology 2013; 38: 2140-2151.
174. Fehm-Wolfsdorf G, Born J, Voigt K-H, Fehm H-L. Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. Psychoneuroendocrinology 1984; 9: 285-292.
175. Heinrichs M, Meinlschmidt G, Wippich W, Ehlert U, Hellhammer DH. Selective amnesic effects of oxytocin on human memory. Physiol Behav 2004; 83: 31-38.
176. Weigand A, Feeser M, Gärtner M, Brandt E, Fan Y, Fuge P, Böker H, Bajbouj M, Grimm S. Effects of intranasal oxytocin prior to encoding and retrieval on recognition memory. Psychopharmacology 2013; 227: 321-329.
177. Bruins J, Hijman R, Van Ree JM. Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects. Peptides 1992; 13: 461-468.
178. Churchland PS, Winkielman P. Modulating social behavior with oxytocin: how does it work? What does it mean? Horm Behav 2012; 61: 392-399.
179. Call J, Tomasello M. Does the chimpanzee have a theory of mind? 30 years later. Trends Cogn Sci 2008; 12: 187-192.
180. Spunt RP, Meyer ML, Lieberman MD. The default mode of human brain function primes the intentional stance. J Cogn Neurosci 2015; 27: 1116-1124.
181. Baron-Cohen S, Leslie AM, Frith UTA. Does the autistic child have a 'theory of mind'? Cognition 1985; 21: 37-46.
182. Dennett DC. Intentional systems. J Philos 1971; 67: 87-106.
183. Heider F, Simmel M. An experimental study of apparent behavior. Am J Psychol 1944; 57: 243-259.
184. Saxe RR, Whitfield-Gabrieli S, Scholz J, Pelphrey KA. Brain regions for perceiving and reasoning about other people in school-aged children. Child Dev 2004; 80: 1197-1209.
185. Saxe R, Kanwisher N. People thinking about thinking people. The role of the temporo-parietal junction in 'theory of mind'. NeuroImage 2003; 19: 1835-1842.
186. Dayan E, Sella I, Mukovskiy A, Douek Y, Giese MA, Malach R, Flash T. The default mode network differentiates biological from non-biological motion. Cereb Cortex 2014; doi:10.1093/cercor/bhu199.
187. Happé FG. An advanced test of theory of mind: understanding of story characters' thoughts and feelings by able autistic, mentally handicapped, and normal children and adults. J Autism Dev Disord 1994; 24: 129-154.
188. Baron-Cohen S, Jolliffe T, Mortimore C, Robertson M. Another advanced test of theory of mind: evidence from very high functioning adults with autism or Asperger syndrome. J Child Psychol Psychiatry 1997; 38: 813-822.
189. Dziobek I, Fleck S, Kalbe E, Rogers K, Hassenstab J, Brand M, Kessler J, Woike JK, Wolf OT, Convit A. Introducing MASC: a movie for the assessment of social cognition. J Autism Dev Disord 2006; 36: 623-636.
190. Westerhof-Evers HJ, Visser-Keizer AC, McDonald S, Spikman JM. Performance of healthy subjects on an ecologically valid test for social cognition: the short, Dutch Version of The Awareness of Social Inference Test (TASIT). J Clin Exp Neuropsychol 2014; 36: 1031-1041.
191. Johansson G. Visual perception of biological motion and a model for its analysis. Percept Psychophys 1973; 14: 201-211.
192. Blair RJR. The neurobiology of psychopathic traits in youths. Nat Rev Neurosci 2013; 14: 786-799.
193. Dziobek I, Rogers K, Fleck S, Bahnemann M, Heekeren HR, Wolf OT, Convit A. Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). J Autism Dev Disord 2008; 38: 464-473.
194. Dawel A, O'Kearney R, McKone E, Palermo R. Not just fear and sadness: meta-analytic evidence of pervasive emotion recognition deficits for facial and vocal expressions in psychopathy. Neurosci Biobehav Rev 2012; 36: 2288-2304.
195. Pardini DA, Byrd ' AL. Perceptions of aggressive conflicts and others' distress in children with callous-unemotional traits: 'I'll show you who's boss, even if you suffer and I get in trouble'. J Child Psychol Psychiatry 2012; 53: 283-291.
196. de Wied M, van Boxtel A, Matthys W, Meeus W. Verbal, facial and autonomic responses to empathy-eliciting film clips by disruptive male adolescents with high versus low callous-unemotional traits. J Abnorm Child Psychol 2012; 40: 211-223.
197. Murphy RO, Ackermann KA, Handgraaf MJJ. Measuring social value orientation. Judgm Decis Mak 2011; 6: 771-781.
198. Moore AB, Clark BA, Kane MJ. Who shalt not kill? Individual differences in working memory capacity, executive control, and moral judgment. Psychol Sci 2008; 19: 549-557.
199. Blair RJR. Fine cuts of empathy and the amygdala: dissociable deficits in psychopathy and autism. Q J Exp Psychol 2008; 61: 157-170.
200. Lockwood PL, Bird G, Bridge M, Viding E. Dissecting empathy: high levels of psychopathic and autistic traits are characterized by difficulties in different social information processing domains. Front Hum Neurosci 2013; 7: 760.
201. Jones AP, Happé FGE, Gilbert F, Burnett S, Viding E. Feeling, caring, knowing: different types of empathy deficit in boys with psychopathic tendencies and autism spectrum disorder. J Child Psychol Psychiatry 2010; 51: 1188-1197.
202. Sharp C, Vanwoerden S. Social cognition: empirical contribution. The developmental building blocks of psychopathic traits: revisiting the role of theory of mind. J Pers Disord 2014; 28: 78-95.
203. Assaf M, Hyatt CJ, Wong CG, Johnson MR, Schultz RT, Hendler T, Pearlson GD. Mentalizing and motivation neural function during social interactions in autism spectrum disorders. NeuroImage 2013; 3: 321-331.
204. Assaf M, Jagannathan K, Calhoun VD, Miller L, Stevens MC, Sahl R, O'Boyle JG, Schultz RT, Pearlson GD. Abnormal functional connectivity of default mode sub-networks in autism spectrum disorder patients. NeuroImage 2010; 53: 247-256.
205. Kaiser MD, Pelphrey KA. Disrupted action perception in autism: behavioral evidence, neuroendophenotypes, and diagnostic utility. Dev Cogn Neurosci 2012; 2: 25-35.
206. Moran JM, Young LL, Saxe R, Lee SM, O'Young D, Mavros PL, Gabrieli JD. Impaired theory of mind for moral judgment in high-functioning autism. Proc Natl Acad Sci USA 2011; 108: 2688-2692.
207. Crespi B, Stead P, Elliot M. Evolution in health and medicine Sackler colloquium: comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA 2010; 107(Suppl): 1736-1741.
208. Backasch B, Straube B, Pyka M, Klöhn-Saghatolislam F, Müller MJ, Kircher TTJ, Leube DTD, Bacjasch B, Klon-Saghatolislam F, Muller M. Hyperintentionality during automatic perception of naturalistic cooperative behavior in patients with schizophrenia. Soc Neurosci 2013; 8: 489-504.
209. Wu N, Li Z, Su Y. The association between oxytocin receptor gene polymorphism (OXTR) and trait empathy. J Affect Disord 2012; 138: 468-472.
210. Uzefovsky F, Shalev I, Israel S, Edelman S, Raz Y, Mankuta D, Knafo-Noam A, Ebstein RP. Oxytocin receptor and vasopressin receptor 1a genes are respectively associated with emotional and cognitive empathy. Horm Behav 2015; 67: 60-65.
211. Laursen HR, Siebner HR, Haren T, Madsen K, Grønlund R, Hulme O, Henningsson S. Variation in the oxytocin receptor gene is associated with behavioral and neural correlates of empathic accuracy. Front Behav Neurosci 2014; 8: 423.
212. Smith KE, Porges EC, Norman GJ, Connelly JJ, Decety J. Oxytocin receptor gene variation predicts empathic concern and autonomic arousal while perceiving harm to others. Soc Neurosci 2014; 9: 1-9.
213. Rodrigues SM, Saslow LR, Garcia N, John OP, Keltner D. Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc Natl Acad Sci USA 2009; 106: 21437-21441.
214. Lucht MJ, Barnow S, Sonnenfeld C, Ulrich I, Grabe HJ, Schroeder W, Völzke H, Freyberger HJ, John U, Herrmann FH, Kroemer H, Rosskopf D. Associations between the oxytocin receptor gene (OXTR) and 'mind-reading' in humans - an exploratory study. Nord J Psychiatry 2013; 67: 15-21.
215. Wade M, Hoffmann TJ, Wigg K, Jenkins JM. Association between the oxytocin receptor (OXTR) gene and children's social cognition at 18 months. Genes Brain Behav 2014; 13: 603-610.
216. Palgi S, Klein E, Shamay-Tsoory SG. Intranasal administration of oxytocin increases compassion toward women. Soc Cogn Affect Neurosci 2014; 10: 311-317.
217. Hurlemann R, Patin A, Onur OA, Cohen MX, Baumgartner T, Metzler S, Dziobek I, Gallinat J, Wagner M, Maier W, Kendrick KM. Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci 2010; 30: 4999-5007.
218. Abu-Akel A, Palgi S, Klein E, Decety J, Shamay-Tsoory S. Oxytocin increases empathy to pain when adopting the other- but not the self-perspective. Soc Neurosci 2015; 10: 7-15.
219. Riem MME, Bakermans-Kranenburg MJ, Huffmeijer R, van IJzendoorn MH. Does intranasal oxytocin promote prosocial behavior to an excluded fellow player? A randomized-controlled trial with Cyberball. Psychoneuroendocrinology 2013; 38: 1418-1425.
220. Krueger F, Parasuraman R, Moody L, Twieg P, de Visser E, McCabe K, O'Hara M, Lee MR. Oxytocin selectively increases perceptions of harm for victims but not the desire to punish offenders of criminal offenses. Soc Cogn Affect Neurosci 2013; 8: 494-498.
221. Zak PJ, Stanton AA, Ahmadi S. Oxytocin increases generosity in humans. PLoS One 2007; 2: e1128.
222. Leknes S, Wessberg J, Ellingsen DM, Chelnokova O, Olausson H, Laeng B. Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions. Soc Cogn Affect Neurosci 2013; 8: 741-749.
223. Singer T, Snozzi R, Bird G, Petrovic P, Silani G, Heinrichs M, Dolan RJ. Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain. Emotion 2008; 8: 781-791.
224. Tabak B, Meyer M, Castle E, Dutcher J, Irwin M, Han J, Lieberman MEN. Vasopressin, but not oxytocin, increases empathic concern among individuals who received higher levels of paternal warmth: a randomized controlled trial. Psychoneuroendocrinology 2015; 51: 253-261.
225. Barraza JA, Zak PJ. Empathy toward strangers triggers oxytocin release and subsequent generosity. Ann NY Acad Sci 2009; 1167: 182-189.
226. Moll I, Heid H, Moll R. Cytokeratin analysis of pilomatrixoma: changes in cytokeratin-type expression during differentiation. J Invest Dermatol 1988; 91: 251-257.
227. Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC. Oxytocin improves 'mind-reading' in humans. Biol Psychiatry 2007; 61: 731-733.
228. Feeser M, Fan Y, Weigand A, Hahn A, Gärtner M, Böker H, Grimm S, Bajbouj M. Oxytocin improves mentalizing - pronounced effects for individuals with attenuated ability to empathize. Psychoneuroendocrinology 2015; 53: 223-232.
229. Woolley JD, Chuang B, Lam O, Lai W, O'Donovan A, Rankin KP, Mathalon DH, Vinogradov S. Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology 2014; 47: 116-125.
230. Kuypers KPC, De Torre R, Farre M, Yubero-lahoz S, Dziobek I, Van Den Bos W, Ramaekers JG, de la Torre R, Van den Bos W. No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation. PLoS One 2014; 9: e100719.
231. Bedi G, Hyman D, de Wit H. Is ecstasy an 'empathogen'? Effects of ±3, 4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Behav Brain Res 2010; 68: 1134-1140.
232. Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Preller KH, Quednow BB, Liechti ME. MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci 2013; 9: 1645-1652.
233. Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME. Differential effects of MDMA and methylphenidate on social cognition. J Psychopharmacol 2014; 28: 847-856.
234. Shulgin AAT, Nichols E, Nichols DE, Stillman R, Willette R, Eds. Characterization of three new psychotomimetics. Pharmacol Hallucinogen 1978; 2: 74-83.
235. Hunt GE, McGregor IS, Cornish JL, Callaghan PD. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Res Bull 2011; 86: 65-73.
236. Hagino Y, Takamatsu Y, Yamamoto H, Iwamura T, Murphy DL, Uhl GR, Sora I, Ikeda K. Effects of MDMA on extracellular dopamine and serotonin levels in mice lacking dopamine and/or serotonin transporters. Curr Neuropharmacol 2011; 9: 91-95.
237. Hasler F, Studerus E, Lindner K, Ludewig S, Vollenweider FX. Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. J Psychopharmacol 2009; 23: 923-935.
238. Dumont GJH, Sweep FCGJ, van der Steen R, Hermsen R, Donders ART, Touw DJ, van Gerven JMA, Buitelaar JK, Verkes RJ, Van Der Steen R, Hospitals TH, Hague T, Van Gerven JMA. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Soc Neurosci 2009; 4: 359-366.
239. Rozas C, Loyola S, Ugarte G, Zeise ML, Reyes-Parada M, Pancetti F, Rojas P, Morales B. Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism. Eur Neuropsychopharmacol 2012; 22: 584-595.
240. Crockett MJ, Clark L, Hauser MD, Robbins TW. Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci USA 2010; 107: 17433-17438.
241. Emery NJ, Clayton NS. Effects of experience and social context on prospective caching strategies by scrub jays. Nature 2001; 414: 443-446.
242. Dally JM, Emery NJ, Clayton NS. Food-caching western scrub-jays keep track of who was watching when. Science 2006; 312: 1662-1665.
243. Flombaum JI, Santos LR, Haven N. Rhesus monkeys attribute perceptions to others. Curr Biol 2005; 15: 447-452.
244. Langford DJ, Crager SE, Shehzad Z, Smith SB, Sotocinal SG, Levenstadt JS, Chanda ML, Levitin DJ, Mogil JS. Social modulation of pain as evidence for empathy in mice. Science 2006; 312: 1967-1970.
245. Panksepp J. Behavior. Empathy and the laws of affect. Science 2011; 334: 1358-1359.
246. 2+ channels in ACC. Nat Neurosci 2010; 13: 482-488.
247. Ben-Ami Bartal I, Decety J, Mason P. Empathy and pro-social behavior in rats. Science 2011; 334: 1427-1430.
248. Haas BW, Anderson IW, Smith JM. Navigating the complex path between the oxytocin receptor gene (OXTR) and cooperation: an endophenotype approach. Front Hum Neurosci 2013; 7: 1-6.
249. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943; 2: 217-250.
250. Centers for Disease Control Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014; 63: 1-21.
251. Bettelheim B. Joey: a mechanical boy. Sci Am 1959; 200: 116-120 passim.
252. Dölen G, Bear MF. Fragile X syndrome and autism: from disease model to therapeutic targets. J Neurodev Disord 2009; 1: 133-140.
253. Verkerk A, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Refner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen G-JB, Bionden LAJ, Riggins GJ, Chastain SJL, Kunst C, Gaijaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in Fragile X syndrome. Cell 1991; 65: 905-914.
254. Amir RE, Van Den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185-188.
255. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee Y-H, Hicks J, Spence SJ, Lee AT, Puura K, Lehtimäki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King M-C, Skuse D, Geschwind DH, Gilliam TC, Ye K, Wigler M. Strong association of de novo copy number mutations with autism. Science 2007; 316: 445-449.
256. Morrow EM, Yoo S-Y, Flavell SW, Kim T-K, Lin Y, Hill RS, Mukaddes NM, Balkhy S, Gascon G, Hashmi A, Al-Saad S, Ware J, Joseph RM, Greenblatt R, Gleason D, Ertelt JA, Apse KA, Bodell A, Partlow JN, Barry B, Yao H, Markianos K, Ferland RJ, Greenberg ME, Walsh CA. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008; 321: 218-223.
257. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PMA, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SFA, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459: 569-573.
258. Orabona GM, Griesi-Oliveira K, Vadasz E, Bulcão VLS, Takahashi VNVO, Moreira ES, Furia-Silva M, Ros-Melo AMS, Dourado F, Matioli SR, Matioli R, Otto P, Passos-Bueno MR. HTR1B and HTR2C in autism spectrum disorders in Brazilian families. Brain Res 2009; 1250: 14-19.
259. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, Salyakina D, Imielinski M, Bradfield JP, Sleiman PMA, Kim CE, Hou C, Frackelton E, Chiavacci R, Takahashi N, Sakurai T, Rappaport E, Lajonchere CM, Munson J, Estes A, Korvatska O, Piven J, Sonnenblick LI, Alvarez Retuerto AI, Herman EI, Dong H, Hutman T, Sigman M, Ozonoff S, Klin A, Owley T, Sweeney JA, Brune CW, Cantor RM, Bernier R, Gilbert JR, Cuccaro ML, McMahon WM, Miller J, State MW, Wassink TH, Coon H, Levy SE, Schultz RT, Nurnberger JI, Haines JL, Sutcliffe JS, Cook EH, Minshew NJ, Buxbaum JD, Dawson G, Grant SFA, Geschwind DH, Pericak-Vance MA, Schellenberg GD, Hakonarson H. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009; 459: 528-533.
260. Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009; 461: 802-808.
261. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin C-F, Stevens C, Wang L-S, Makarov V, Polak P, Yoon S, Maguire J, Crawford EL, Campbell NG, Geller ET, Valladares O, Schafer C, Liu H, Zhao T, Cai G, Lihm J, Dannenfelser R, Jabado O, Peralta Z, Nagaswamy U, Muzny D, Reid JG, Newsham I, Wu Y, Lewis L, Han Y, Voight BF, Lim E, Rossin E, Kirby A, Flannick J, Fromer M, Shakir K, Fennell T, Garimella K, Banks E, Poplin R, Gabriel S, DePristo M, Wimbish JR, Boone BE, Levy SE, Betancur C, Sunyaev S, Boerwinkle E, Buxbaum JD, Cook EH, Devlin B, Gibbs RA, Roeder K, Schellenberg GD, Sutcliffe JS, Daly MJ. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012; 485: 242-245.
262. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246-250.
263. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, El-Fishawy P, Murtha RC, Choi M, Overton JD, Bjornson RD, Carriero NJ, Meyer KA, Bilguvar K, Mane SM, Sestan N, Lifton RP, Günel M, Roeder K, Geschwind DH, Devlin B, State MW. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485: 237-241.
264. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, Singh T, Klei L, Kosmicki J, Shih-Chen F, Aleksic B, Biscaldi M, Bolton PF, Brownfeld JM, Cai J, Campbell NG, Carracedo A, Chahrour MH, Chiocchetti AG, Coon H, Crawford EL, Curran SR, Dawson G, Duketis E, Fernandez BA, Gallagher L, Geller E, Guter SJ, Hill RS, Ionita-Laza J, Jimenz Gonzalez P, Kilpinen H, Klauck SM, Kolevzon A, Lee I, Lei I, Lei J, Lehtimäki T, Lin C-F, Ma'ayan A, Marshall CR, McInnes AL, Neale B, Owen MJ, Ozaki N, Parellada M, Parr JR, Purcell S, Puura K, Rajagopalan D, Rehnström K, Reichenberg A, Sabo A, Sachse M, Sanders SJ, Schafer C, Schulte-Rüther M, Skuse D, Stevens C, Szatmari P, Tammimies K, Valladares O, Voran A, Li-San W, Weiss LA, Willsey AJ, Yu TW, Yuen RKC, Cook EH, Freitag CM, Gill M, Hultman CM, Lehner T, Palotie A, Schellenberg GD, Sklar P, State MW, Sutcliffe JS, Walsh CA, Scherer SW, Zwick ME, Barett JC, Cutler DJ, Roeder K, Devlin B, Daly MJ, Buxbaum JD. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014; 515: 209-215.
265. Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, Smith JD, Paeper B, Nickerson DA, Dea J, Dong S, Gonzalez LE, Mandell JD, Mane SM, Murtha MT, Sullivan CA, Walker MF, Waqar Z, Wei L, Willsey AJ, Yamrom B, Lee Y, Grabowska E, Dalkic E, Wang Z, Marks S, Andrews P, Leotta A, Kendall J, Hakker I, Rosenbaum J, Ma B, Rodgers L, Troge J, Narzisi G, Yoon S, Schatz MC, Ye K, McCombie WR, Shendure J, Eichler EE, State MW, Wigler M. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014; 515: 216-221.
266. McCarroll SA, Feng G, Hyman SE. Genome-scale neurogenetics: methodology and meaning. Nat Neurosci 2014; 17: 756-763.
267. Dölen G, Osterweil E, Rao BSS, Smith GB, Auerbach BD, Chattarji S, Bear MF. Correction of Fragile X syndrome in mice. Neuron 2007; 56: 955-962.
268. Portmann T, Yang M, Mao R, Panagiotakos G, Ellegood J, Dolen G, Bader PL, Grueter BA, Goold C, Fisher E, Clifford K, Rengarajan P, Kalikhman D, Loureiro D, Saw NL, Zhengqui Z, Miller MA, Lerch JP, Henkelman RM, Shamloo M, Malenka RC, Crawley JN, Dolmetsch RE. Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome. Cell Rep 2014; 7: 1077-1092.
269. Rothwell PE, Fuccillo MV, Maxeiner S, Hayton SJ, Gokce O, Lim BK, Fowler SC, Malenka RC, Südhof TC. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 2014; 158: 198-212.
270. Zoghbi HY, Bear MF. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol 2012; 4: a009886.
271. Darnell JC, Klann E. The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci 2013; 16: 1530-1536.
272. D'Antoni S, Spatuzza M, Bonaccorso CM, Musumeci SA, Ciranna L, Nicoletti F, Huber KM, Catania MV. Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with intellectual disability and autism. Neurosci Biobehav Rev 2014; 46; 228-241.
273. Dölen G, Carpenter RL, Ocain TD, Bear MF. Mechanism-based approaches to treating Fragile X. Pharmacol Ther 2010; 127: 78-93.
274. Dölen G, Malenka RC. The emerging role of nucleus accumbens oxytocin in social cognition. Biol Psychiatry 2014; 76: 354-355.
275. Grabrucker AM, Schmeisser MJ, Schoen M, Boeckers TM. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol 2011; 21: 594-603.
276. Ghosh A, Michalon A, Lindemann L, Fontoura P, Santarelli L. Drug discovery for autism spectrum disorder: challenges and opportunities. Nat Rev Drug Discovery 2013; 12: 777-790.
277. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 2013; 493: 327-337.
278. Qiu S, Aldinger KA, Levitt P. Modeling of autism genetic variations in mice: focusing on synaptic and microcircuit dysfunctions. Dev Neurosci 2012; 34: 88-100.
279. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13: 1161-1169.
280. Tchaconas A, Adesman A. Autism spectrum disorders: a pediatric overview and update. Curr Opin Pediatr 2013; 25: 130-144.
281. Insel TR, Gelhard R, Shapiro LE. The comparative distribution of forebrain receptors for neurohypophyseal peptides in monogamous and polygamous mice. Neuroscience 1991; 43: 623-630.
282. Young LJ, Barrett CE. Neuroscience. Can oxytocin treat autism? Science 2015; 347: 825-826.
283. Markram K, Markram H. The intense world theory - a unifying theory of the neurobiology of autism. Front Hum Neurosci 2010; 4: 224.
284. Chevallier C, Kohls G, Troiani V, Brodkin ES, Schultz RT. The social motivation theory of autism. Trends Cogn Sci 2012; 16: 231-239.
285. Ventola P, Yang DYJ, Friedman HE, Oosting D, Wolf J, Sukhodolsky DG, Pelphrey KA. Heterogeneity of neural mechanisms of response to pivotal response treatment. Brain Imaging Behav 2015; 9: 74-78.
286. Sims TB, Neufeld J, Johnstone T, Chakrabarti B. Autistic traits modulate frontostriatal connectivity during processing of rewarding faces. Soc Cogn Affect Neurosci 2014; 9: 2010-2016.
287. Chevallier C, Parish-Morris J, Tonge N, Le L, Miller J, Schultz RT. Susceptibility to the audience effect explains performance gap between children with and without autism in a theory of mind task. J Exp Psychol 2014; 143: 972-979.
288. Dufour N, Redcay E, Young L, Mavros PL, Moran JM, Triantafyllou C, Gabrieli JDE, Saxe R. Similar brain activation during false belief tasks in a large sample of adults with and without autism. PLoS One 2013; 8: e75468.
289. Peng DX, Kelley RG, Quintin E, Raman M, Thompson PM, Reiss AL. Cognitive and behavioral correlates of caudate subregion shape variation in Fragile X syndrome. Hum Brain Mapp 2014; 35: 2861-2868.
290. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla M, Abrans M. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med 1995; 1: 159-167.
291. Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, Sebastiano V, Krawisz A, Froehlich W, Bernstein JA, Hallmayer JF, Dolmetsch RE. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 2013; 503: 267-271.
292. Chen M, Wan Y, Ade K, Ting J, Feng G, Calakos N. Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J Neurosci 2011; 31: 9563-9573.
293. Smith LN, Jedynak JP, Fontenot MR, Hale CF, Dietz KC, Taniguchi M, Thomas FS, Zirlin BC, Birnbaum SG, Huber KM, Thomas MJ, Cowan CW. Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration. Neuron 2014; 82: 645-658.
294. Wang H, Wu L-J, Kim SS, Lee FJS, Gong B, Toyoda H, Ren M, Shang Y-Z, Xu H, Liu F, Zhao M-G, Zhuo M. FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 2008; 59: 634-647.
295. Thurman AJ, McDuffie A, Hagerman R, Abbeduto L. Psychiatric symptoms in boys with Fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder. Res Dev Disabil 2014; 35: 1072-1086.
296. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ. Autism profiles of males with Fragile X syndrome. Am J Ment Retard 2008; 113: 427-438.
297. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. 2003: 193-198.
298. Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S. Oxytocin increases retention of social cognition in autism. Biol Psychiatry 2007; 61: 498-503.
299. Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, Hickie IB. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 2010; 67: 692-694.
300. Andari E, Duhamel J-R, Zalla T, Herbrecht E, Leboyer M, Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 2010; 107: 4389-4394.
301. Hall SS, Lightbody AA, McCarthy BE, Parker KJ, Reiss AL. Effects of intranasal oxytocin on social anxiety in males with Fragile X syndrome. Psychoneuroendocrinology 2012; 37: 509-518.
302. Anagnostou E, Soorya L, Chaplin W, Bartz J, Halpern D, Wasserman S, Wang AT, Pepa L, Tanel N, Kushki A, Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Mol Autism 2012; 3: 16.
303. Dadds MR, MacDonald E, Cauchi A, Williams K, Levy F, Brennan J. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord 2014; 44: 521-531.
304. Domes G, Kumbier E, Heinrichs M, Herpertz SC. Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with Asperger syndrome. Neuropsychopharmacology 2014; 39: 698-706.
305. Watanabe T, Abe O, Kuwabara H, Yahata N, Takano Y, Iwashiro N, Natsubori T, Aoki Y, Takao H, Kawakubo Y, Kamio Y, Kato N, Miyashita Y, Kasai K, Yamasue H. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity. JAMA Psychiatry 2013; 71: 166-175.
306. Aoki Y, Yahata N, Watanabe T, Takano Y, Kawakubo Y, Kuwabara H, Iwashiro N, Natsubori T, Inoue H, Suga M, Takao H, Sasaki H, Gonoi W, Kunimatsu A, Kasai K, Yamasue H. Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism. Brain 2014; 137: 3073-3086.
307. Guastella AJ, Gray KM, Rinehart NJ, Alvares GA, Tonge BJ, Hickie IB, Keating CM, Cacciotti-Saija C, Einfeld SL. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J Child Psychol Psychiatry 2015; 56: 444-452.
308. Preti A, Melis M, Siddi S, Vellante M, Doneddu G, Fadda R. Oxytocin and autism: a systematic review of randomized controlled trials. J Child Adolesc Psychopharmacol 2014; 24: 54-68.
309. Bakermans-Kranenburg MJ, Van Ijzendoorn MH. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiat 2013; 3: e258.
310. Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008; 58: 639-650.
311. Bales KL, Perkeybile AM, Conley OG, Lee MH, Guoynes CD, Downing GM, Yun CR, Solomon M, Jacob S, Mendoza SP. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol Psychiatry 2013; 74: 180-188.
312. Bales KL, Solomon M, Jacob S, Crawley JN, Silverman JL, Larke RH, Sahagun E, Puhger KR, Pride MC, Mendoza SP. Long-term exposure to intranasal oxytocin in a mouse autism model. Transl Psychiatry 2014; 4: e480.
313. Huang H, Michetti C, Busnelli M, Managò F, Sannino S, Scheggia D, Giancardo L, Sona D, Murino V, Chini B, Scattoni ML, Papaleo F. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology 2014; 39: 1102-1114.
314. Peters S, Slattery DA, Uschold-Schmidt N, Reber SO, Neumann ID. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology 2014; 42: 225-236.
315. Jacquemont S, Berry-Kravis E, Hagerman R, von Raison F, Gasparini F, Apostol G, Ufer M, Des Portes V, Gomez-Mancilla B. The challenges of clinical trials in Fragile X syndrome. Psychopharmacology 2014; 231: 1237-1250.
316. Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK. Outcome measures for clinical trials in Fragile X syndrome. J Dev Behav Pediatr 2013; 34: 508-522.
317. McEwen BB. Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research. Adv Pharmacol 2004; 50: 531-592, 655-708.
318. Peñagarikano O, Lázaro MT, Lu X, Gordon A, Dong H, Lam HA, Peles E, Maidment NT, Murphy NP, Yang XW, Golshani P, Geschwind DH. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci Transl Med 2015; 7: 271
319. Suraev AS, Bowen MT, Ali SO, Hicks C, Ramos L, McGregor IS. Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood. Horm Behav 2014; 65: 488-496.
320. Bowen MT, McGregor I. Oxytocin and vasopressin modulate the social response to threat: a preclinical study. Int J Neuropsychopharmacol 2014; 17: 1621-1633.
321. Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS One 2011; 6: e27237.
322. Carson DS, Cornish JL, Guastella AJ, Hunt GE, McGregor IS. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology 2010; 58: 38-43.
323. Qi J, Yang J-Y, Wang F, Zhao Y-N, Song M, Wu C-F. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009; 56: 856-865.
324. Lee MR, Wehring HJ, McMahon RP, Linthicum J, Cascella N, Liu F, Bellack A, Buchanan RW, Strauss GP, Contoreggi C, Kelly DL. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study. Schizophr Res 2013; 145: 110-115.
325. Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M, Hosseini SMR, Tajdini M, Ghaleiha A, Akhondzadeh S. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study. CNS Drugs 2013; 27: 57-65.
326. Monte OD, Noble PL, Turchi J, Cummins A, Averbeck BB, Dal Monte O. CSF and blood oxytocin concentration changes following intranasal delivery in macaque. PLoS One 2014; 9: e103677.
327. Evans SL, Dal Monte O, Noble P, Averbeck BB, Dal O. Intranasal oxytocin effects on social cognition: a critique. Brain Res 2014; 1580: 69-77.
328. Dhuria SV, Hanson LR, Frey WH II. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 2010; 99: 1654-1673.
329. De Dreu CKW, Greer LL, Van Kleef GA, Shalvi S, Handgraaf MJJ, De Dreu CKW, Van Kleef GA. Oxytocin promotes human ethnocentrism. Proc Natl Acad Sci USA 2011; 108: 1262-1266.
330. Hattori T, Kanno K, Nagasawa M, Nishimori K, Mogi K, Kikusui T. Impairment of interstrain social recognition during territorial aggressive behavior in oxytocin receptor-null mice. Neurosci Res 2015; 90: 90-94.
331. Modi ME, Connor-Stroud F, Landgraf R, Young LJ, Parr LA. Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques. Psychoneuroendocrinology 2014; 45: 49-57.
332. Pedersen CA, Vadlamudi SV, Boccia ML, Amico JA. Maternal behavior deficits in nulliparous oxytocin knockout mice. Genes Brain Behav 2006; 5: 274-281.
333. Akther S, Korshnova N, Zhong J, Liang M, Cherepanov SM, Lopatina O, Komleva YK, Salmina AB, Nishimura T, Fakhrul AA, Hirai H, Kato I, Yamamoto Y, Takasawa S, Okamoto H, Higashida H. CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice. Mol Brain 2013; 6: 41.
334. Kojima S, Alberts JR. Oxytocin mediates the acquisition of filial, odor-guided huddling for maternally-associated odor in preweanling rats. Horm Behav 2011; 60: 549-558.
335. Kent K, Arientyl V, Khachatryan MM, Wood RI. Oxytocin induces a conditioned social preference in female mice. J Neuroendocrinol 2013; 25: 803-810.
336. Leknes S, Wessberg J, Ellingsen DM, Chelnokova O, Olausson H, Laeng B. Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions. Soc Cogn Affect Neurosci 2013; 8: 741-749.
337. Moll I, Heid H, Moll R. Cytokeratin analysis of pilomatrixoma: changes in cytokeratin-type expression during differentiation. J Invest Dermatol 1988; 91: 251-257.
338. Wu N, Li Z, Su Y. The association between oxytocin receptor gene polymorphism (OXTR) and trait empathy. J Affect Disord 2012; 138: 468-472.
339. Lucht MJ, Barnow S, Sonnenfeld C, Ulrich I, Grabe HJ, Schroeder W, Völzke H, Freyberger HJ, John U, Herrmann FH, Kroemer H, Rosskopf D. Associations between the oxytocin receptor gene (OXTR) and 'mind-reading' in humans -an exploratory study. Nord J Psychiatry 2013; 67: 15-21.
340. Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3, 4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 2013; 27: 28-39.
341. Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R. The safety and efficacy of {+/-}3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 2011; 25: 439-452.
342. Bouso JC, Doblin R, Farré M, Alcázar MÁ, Gómez-jarabo G. MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder. J Psychoactive Drugs 2008; 40: 225-236.
343. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011; 12: 524-538.
344. Pedersen CA, Gibson CM, Rau SW, Salimi K, Smedley KL, Casey RL, Leserman J, Jarskog LF, Penn DL. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr Res 2011; 132: 50-53.